1)Iida T, Kishi S, Hagimura N et al:Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508-512, 1999
2)Cardillo Piccolo F, Eandi CM, Ventre L et al:Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752-763, 2003
3)Chan WM, Lai TY, Lai RY et al:Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy one-year results of a randomized controlled trial. Ophthalmology 115:1756-1765, 2008
4)Chan WM, Lai TY, Lai RY et al:Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy:one-year results of a prospective study. Retina 28:85-93, 2008
5)Reibaldi M, Cardascia N, Longo A et al:Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy:a nonrandomized clinical trial. Am J Ophthalmol 149:307-315, 2010
6)Lee PY, Kim KS, Lee WK et al:Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous choriorethinopathy. J J Ophthalmology 53:52-56, 2009
7)Lim SJ, Roh MI, Kwon OW:Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina 30:100-106, 2009
8)Inoue M, Kadonosono K, Watanabe Y et al:Results of one-year follow-up examination after intravitreal bevasizumab administration for chronic central serous chorioretinopathy. Ophthalmologica 225:37-40, 2010
9)Lim JW, Kim MU, Shin MC:Aqueous and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy. Retina 30:1465-1471, 2010
10)三田村佳典,山本修一:眼底自発蛍光.臨眼 62:433-439,2008
11)Spaide RF, Klancnik JM:Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology 112:825-833, 2005